PAVmed Inc. Common Stock (PAVM) is a publicly traded Healthcare sector company. As of September 10, 2026, PAVM trades at $4.52 with a market cap of $37.74M and a P/E ratio of -0.51. PAVM moved +0.00% today. Year to date, PAVM is -31.76%; over the trailing twelve months it is -64.96%. Its 52-week range spans $3.85 to $28.44. Analyst consensus is buy with an average price target of $36.50. Rallies surfaces PAVM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover PAVM: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $36.50.
| Metric | Value |
|---|---|
| Price | $4.52 |
| Market Cap | $37.74M |
| P/E Ratio | -0.51 |
| EPS | $-8.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.44 |
| 52-Week Low | $3.85 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $112.00K |
| Net Income | $-16.43M |
| Gross Margin | -220.54% |
2 analysts cover PAVM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $36.50.